Perceptive Advisors - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$60,283,978
+47.5%
4,043,191
+8.3%
2.01%
+70.0%
Q2 2023$40,879,142
+20.1%
3,733,255
-4.4%
1.18%
+17.7%
Q1 2023$34,036,384
+665.7%
3,903,255
+450.5%
1.00%
+704.0%
Q4 2022$4,445,386
-42.9%
708,993
-53.4%
0.12%
-40.5%
Q3 2019$7,784,000
-71.9%
1,520,355
-60.6%
0.21%
-66.9%
Q2 2019$27,657,000
-50.6%
3,862,821
-8.3%
0.64%
-59.8%
Q1 2019$55,946,000
+188.6%
4,212,821
+71.1%
1.58%
+113.8%
Q4 2018$19,382,000
-36.2%
2,462,821
-10.2%
0.74%
-9.2%
Q3 2018$30,390,000
-17.4%
2,742,8210.0%0.81%
-15.8%
Q2 2018$36,808,000
+9.1%
2,742,821
-2.1%
0.96%
+2.1%
Q1 2018$33,745,000
+36.6%
2,802,821
+4.4%
0.94%
+15.4%
Q4 2017$24,710,000
-34.8%
2,685,882
-42.9%
0.82%
+13.1%
Q3 2017$37,896,0004,701,7640.72%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,787,094$26,645,57214.80%
Lynx1 Capital Management LP 994,161$14,822,9419.80%
Octagon Capital Advisors LP 3,073,750$45,829,6137.04%
Saturn V Capital Management LP 1,124,459$16,765,6847.02%
Altium Capital Management LP 800,000$11,928,0006.22%
Affinity Asset Advisors, LLC 1,129,376$16,838,9964.74%
ACUTA CAPITAL PARTNERS, LLC 418,000$6,232,3804.18%
Cormorant Asset Management, LP 3,850,000$57,403,5003.35%
SILVERARC CAPITAL MANAGEMENT, LLC 590,000$8,796,9002.67%
MPM BioImpact LLC 610,770$9,106,5812.43%
View complete list of CYMABAY THERAPEUTICS INC shareholders